Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma.
Korsch
E
E
Grote
A
A
Seybold
M
M
Soditt
V
V
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000187:drug effects; D000068438:Brimonidine Tartrate; D002490:Central Nervous System / Q000187:drug effects; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D011810:Quinoxalines / Q000009:adverse effects* / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D011810:Quinoxalines; D000068438:Brimonidine Tartrate